Phase II study of crizotinib in patients with Anaplastic Lymphoma Kinase (ALK) positive Anaplastic Large Cell Lymphoma relapsed/refractory to chemotherapy

Lymphoma
18/08/2020

Am J Hematol. 2020 Aug 18. doi: 10.1002/ajh.25967. Online ahead of print.

NO ABSTRACT